Canada markets closed

Tetra Bio-Pharma Inc. (TBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.1600+0.0050 (+3.23%)
At close: 3:57PM EST
Full screen
Previous Close0.1550
Open0.1600
Bid0.1550 x N/A
Ask0.1600 x N/A
Day's Range0.1450 - 0.1600
52 Week Range0.1350 - 0.3700
Volume3,527,244
Avg. Volume1,536,329
Market Cap57.355M
Beta (5Y Monthly)1.93
PE Ratio (TTM)N/A
EPS (TTM)-0.1030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
    ACCESSWIRE

    Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

    OTTAWA, ON / ACCESSWIRE / March 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company")(TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announces that CEO Dr.

  • Tetra Bio-Pharma Announces Closing of Bought Deal Offering
    CNW Group

    Tetra Bio-Pharma Announces Closing of Bought Deal Offering

    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/OTTAWA, ON, March 2, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development, is pleased to announce it has closed its previously announced bought-deal public offering of units (the "Units") of the Company.

  • Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios
    ACCESSWIRE

    Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios

    Company signs LOI for Nordics and GermanyOTTAWA, ON / ACCESSWIRE / February 25, 2021 /Tetra Bio-Pharma Inc. ("Tetra" or the "Company")(TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announced the signing of a Letter of Intent with DanCann Pharma A/S (SS: DANCAN) for the exclusive distribution of Reduvo™ Adversa® and QIXLEEF™ in Denmark, Norway, Sweden, Finland, and Germany.